Menu

Notable Science Quotes

Eugene Garfield, the cancer moonshot, employee genetic testing, and more

Apr 1, 2017
The Scientist Staff

Eugene Garfield: 1925–2017ILLUSTRATION BY ERICA P. JOHNSON

Everything he did, he was ahead of everybody in so many ways. He was a genius of a very special type. Not only because he had this incredible imagination and brain, but he had incredible tenacity and courage.

—Vitek Tracz, publisher of Faculty of 1000 and former co-owner of The Scientist, on the passing of Eugene Garfield, the scientometrics pioneer who launched The Scientist in 1986 (February 27)

 

I think that measuring with precision human activity on the climate is something very challenging to do, and there’s tremendous disagreement about the degree of impact, so no, I would not agree that it’s a primary contributor to the global warming that we see.

Newly confirmed US Environmental Protection Agency Administrator Scott Pruitt, on the CNBC program Squawk Box (March 9)

 

It is my hope that this new administration, once it gets organized—and I’m not being facetious—can be as committed and enthusiastic as we were. The only bipartisan thing left in America is the fight against cancer.

Former Vice President Joe Biden, in a speech delivered at this year’s South by Southwest festival in Austin, Texas, about the federal government’s role in cancer research (March 12)

 

To succeed, the Trump administration needs to assume the leadership Biden was given previously as vice president to foster cooperation and collaboration among the various federal agencies and institutions with relevant resources, and to guide [the] moonshot in a direction that maximizes its value to public health.

—Nancy Brinker, founder of the Susan G. Komen breast cancer charity, and journalist Eric Rosenthal, writing in The Hill about how Donald Trump should pursue Barack Obama’s cancer “moonshot” (February 15)

 

His treatment was much easier than what some people have to endure, but I’ve found that physicians who have a cancer experience understand the human side of things and how treatment impacts individuals and families.

—Shelley Fuld Nasso, CEO of the National Coalition for Cancer Survivorship, talking about Donald Trump’s appointment of  Scott Gottlieb— a physician, drug industry financier, and cancer survivor—to lead the US Food and Drug Administration (March 10)

 

It would allow employers to ask employees invasive questions about . . . genetic tests they and their families have undergone . . . [and] to impose stiff financial penalties on employees who choose to keep such information private, thus empowering employers to coerce their employees.

—Nancy Cox, president of the American Society of Human Genetics, in a letter delivered to the House Committee on Education and the Workforce a day before it approved HR 1313, a bill that would allow companies to require their workers to undergo genetic testing or pay fines (March 10)

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.